Characterization of a Folate Transporter in HeLa Cells with a Low pH Optimum and High Affinity for Pemetrexed Distinct from the Reduced Folate Carrier
Open Access
- 15 September 2004
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 10 (18) , 6256-6264
- https://doi.org/10.1158/1078-0432.ccr-04-0645
Abstract
Studies were undertaken to characterize a low pH transport activity in a reduced folate carrier (RFC)-null HeLa-derived cell line (R5). This transport activity has a 20-fold higher affinity for pemetrexed (PMX; Kt, ∼45 nmol/L) than methotrexate (MTX; Kt, ∼1 μmol/L) with comparable Vmax values. The Ki values for folic acid, ZD9331, and ZD1694 were ∼ 400–600 nmol/L, and the Ki values for PT523, PT632, and trimetrexate were >50 μmol/L. The transporter is stereospecific and has a 7-fold higher affinity for the 6S isomer than the 6R isomer of 5-formyltetrahydrofolate but a 4-fold higher affinity for the 6R isomer than the 6S isomer of dideazatetrahydrofolic acid. Properties of RFC-independent transport were compared with transport mediated by RFC at low pH using HepG2 cells, with minimal constitutive low pH transport activity, transfected to high levels of RFC. MTX influx Kt was comparable at pH 7.4 and pH 5.5 (1.7 versus 3.8 μmol/L), but Vmax was decreased 4.5-fold. There was no difference in the Kt for PMX (∼1.2 μmol/L) or the Ki for folic acid (∼130 μmol/L) or PT523 (∼ 0.2 μmol/L) at pH 7.4 and pH 5.5. MTX influx in R5 and HepG2 transfectants at pH 5.5 was trans-stimulated in cells loaded with 5-formyltetrahydrofolate, inhibited by Cl− (HepG2-B > R5), Na+ independent, and uninhibited by energy depletion. Hence, RFC-independent low pH transport activity in HeLa R5 cells is consistent with a carrier-mediated process with high affinity for PMX. Potential alterations in protonation of RFC or the folate molecule as a function of pH do not result in changes in affinity constants for antifolates. Whereas both activities at low pH have similarities, they can be distinguished by folic acid and PT523, agents for which they have very different structural specificities.Keywords
This publication has 34 references indexed in Scilit:
- Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With ChemotherapyJournal of Clinical Oncology, 2004
- A Prominent Low-pH Methotrexate Transport Activity in Human Solid TumorsClinical Cancer Research, 2004
- Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural MesotheliomaJournal of Clinical Oncology, 2003
- Contrasting effects of oncogene expression on two carrier-mediated systems internalizing folate compounds in Fisher rat 3T3 cellsJournal of Cellular Physiology, 2000
- RFC-1 Gene Expression Regulates Folate Absorption in Mouse Small IntestineJournal of Biological Chemistry, 1997
- The kinetics of glucose transport in human red blood cellsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1986
- The transmembrane pH gradient drives uphill folate transport in rabbit jejunum. Direct evidence for folate/hydroxyl exchange in brush border membrane vesicles.Journal of Clinical Investigation, 1985
- Gastrointestinal absorption of folates and antifolatesPharmacology & Therapeutics, 1983
- THE CHARACTERISTICS OF THE MEMBRANE TRANSPORT OF AMETHOPTERIN AND THE NATURALLY OCCURRING FOLATESAnnals of the New York Academy of Sciences, 1971
- A model system for the study of heteroexchange diffusion: Methotrexate-folate interactions in L1210 leukemia and Ehrlich ascites tumor cellsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1971